{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T04:02:09Z","timestamp":1745640129614,"version":"3.40.4"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.thromres.2025.109301","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:08:09Z","timestamp":1741219689000},"page":"109301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical outcomes of direct oral anticoagulants in patients with thrombosis in unusual sites: Insights from a tertiary care center"],"prefix":"10.1016","volume":"249","author":[{"given":"Sergio","family":"Morag\u00f3n-Ledesma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Alonso-Beato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Galeano-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Ordieres-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"L\u00f3pez-Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta-Olimpia","family":"Lago-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Antonio","family":"Alvarez-Sala-Walther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Demelo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2025.109301_bb0005","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jacc.2023.10.038","article-title":"When direct oral anticoagulants should not be standard treatment: JACC state-of-the-art review","volume":"83","author":"Bejjani","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109301_bb0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0042-1757937","article-title":"Upper extremity deep venous thrombosis: etiologies, diagnosis, and updates in therapeutic strategies","volume":"39","author":"Koethe","year":"2022","journal-title":"Semin. Interv. Radiol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109301_bb0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.rce.2024.02.004","article-title":"Cerebral venous thrombosis","volume":"224","author":"Ordieres-Ortega","year":"2024","journal-title":"Rev. Clin. Esp. (Barc.)"},{"issue":"9","key":"10.1016\/j.thromres.2025.109301_bb0020","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.medcli.2023.01.020","article-title":"Mesenteric venous thrombosis","volume":"160","author":"Demelo-Rodr\u00edguez","year":"2023","journal-title":"Med. Clin. (Barc.)"},{"issue":"4","key":"10.1016\/j.thromres.2025.109301_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12517","article-title":"Thromboprophylaxis with rivaroxaban in patients with malignancy and central venous lines (TRIM-Line): a two-center open-label pilot randomized controlled trial","volume":"5","author":"Ikesaka","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109301_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2022.05.014","article-title":"Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: a subgroup analysis of the AVERT Trial","volume":"216","author":"Brandt","year":"2022","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2025.109301_bb0035","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1161\/STR.0000000000000456","article-title":"Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association","volume":"55","author":"Saposnik","year":"2024","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.thromres.2025.109301_bb0040","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1161\/STROKEAHA.122.039579","article-title":"Direct oral anticoagulants versus vitamin K antagonists in cerebral venous thrombosis: a systematic review and meta-analysis","volume":"53","author":"Yaghi","year":"2022","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.thromres.2025.109301_bb0045","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/bloodadvances.2022007397","article-title":"Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study","volume":"6","author":"Ageno","year":"2022","journal-title":"Blood Adv."},{"issue":"12","key":"10.1016\/j.thromres.2025.109301_bb0050","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200104","article-title":"Rivaroxaban prophylaxis in noncirrhotic portal vein thrombosis","volume":"1","author":"Plessier","year":"2022","journal-title":"NEJM Evid."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:49:56Z","timestamp":1745560196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":10,"alternative-id":["S0049384825000507"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109301","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of direct oral anticoagulants in patients with thrombosis in unusual sites: Insights from a tertiary care center","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109301"}}